Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析

◆英語タイトル:Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME45129PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥210,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥315,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company’s product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Australia, Italy, New Zealand, and other Scandinavia regions (Sweden, Norway and Denmark). Tandem is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Tandem Diabetes Care Inc Company Overview
Tandem Diabetes Care Inc Company Snapshot
Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
Tandem Diabetes Care Inc – Pipeline Analysis Overview
Tandem Diabetes Care Inc – Key Facts
Tandem Diabetes Care Inc – Major Products and Services
Tandem Diabetes Care Inc Pipeline Products by Development Stage
Tandem Diabetes Care Inc Pipeline Products Overview
AutoSoft XC
AutoSoft XC Product Overview
Next Generation Gswim
Next Generation Gswim Product Overview
t:connect Mobile – Biometric Authentication
t:connect Mobile – Biometric Authentication Product Overview
t:connect Mobile – Decision Support
t:connect Mobile – Decision Support Product Overview
t:connect Mobile – Health App Integration
t:connect Mobile – Health App Integration Product Overview
t:connect Mobile – Mobile Bolus
t:connect Mobile – Mobile Bolus Product Overview
t:sport
t:sport Product Overview
Tandem Diabetes Care Inc – Key Competitors
Tandem Diabetes Care Inc – Key Employees
Tandem Diabetes Care Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Tandem Diabetes Care Inc, Recent Developments
Mar 02, 2020: Tandem Diabetes Care announces FDA designation of Basal-IQ technology as an interoperable automated glycemic controller
Feb 20, 2020: Data presented at International Diabetes Conference further demonstrate benefits of Tandem Diabetes care automated insulin delivery technologies
Feb 05, 2020: Tandem Diabetes Care recalls t:slim X2 insulin pump
Jan 15, 2020: Tandem Diabetes Care announces commercial launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States
Jan 09, 2020: Tandem Diabetes Care appoints new executive vice president of strategy and corporate development
Jan 02, 2020: FDA approves UVA-developed artificial pancreas
Dec 23, 2019: Dexcom Partners with Tandem Diabetes Care on the t:slim X2 insulin pump in the UK, Sweden, Italy and Spain
Dec 13, 2019: Tandem Diabetes Care announces FDA clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
Dec 13, 2019: FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system
Nov 20, 2019: Tandem Diabetes Care announces Health Canada approval of t:slim X2 Insulin Pump with Basal-IQ predictive low-glucose suspend technology
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
Tandem Diabetes Care Inc Pipeline Products by Equipment Type
Tandem Diabetes Care Inc Pipeline Products by Indication
Tandem Diabetes Care Inc, Key Facts
Tandem Diabetes Care Inc, Major Products and Services
Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage
Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage
AutoSoft XC - Product Status
AutoSoft XC - Product Description
Next Generation Gswim - Product Status
Next Generation Gswim - Product Description
t:connect Mobile - Biometric Authentication - Product Status
t:connect Mobile - Biometric Authentication - Product Description
t:connect Mobile - Decision Support - Product Status
t:connect Mobile - Decision Support - Product Description
t:connect Mobile - Health App Integration - Product Status
t:connect Mobile - Health App Integration - Product Description
t:connect Mobile - Mobile Bolus - Product Status
t:connect Mobile - Mobile Bolus - Product Description
t:sport - Product Status
t:sport - Product Description
Tandem Diabetes Care Inc, Key Employees
Tandem Diabetes Care Inc, Subsidiaries
Glossary

★海外企業調査レポート[Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RCL Foods Ltd. (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd. (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd is an upstream oil and gas exploration and production company that explores, produces, and develops, oil and gas properties in Trinidad and Tobago. The company holds interests, owns, and operates projects such as WD-4 …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Memorial Health System:企業の戦略的SWOT分析
    Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sprouts Farmers Markets, Inc (SFM):企業の財務・戦略的SWOT分析
    Sprouts Farmers Markets, Inc (SFM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Brioche Pasquier S.A.:企業の戦略・SWOT・財務分析
    Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report Summary Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cathay United Bank Co Ltd:企業の戦略・SWOT・財務情報
    Cathay United Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Cathay United Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Acorda Therapeutics Inc (ACOR)-製薬・医療分野:企業M&A・提携分析
    Summary Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. The company’s commercial products include Ampyra (dalfampridine), a treatment to improve walking in patients with multiple …
  • Imobiliaria Construtora Grao-Para SA:企業の戦略・SWOT・財務情報
    Imobiliaria Construtora Grao-Para SA - Strategy, SWOT and Corporate Finance Report Summary Imobiliaria Construtora Grao-Para SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Premier Marketing Public Company Limited:戦略・SWOT・企業財務分析
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Ventana Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • Mostostal Warszawa SA (MSW):企業の財務・戦略的SWOT分析
    Mostostal Warszawa SA (MSW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Vaccinogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vaccinogen Inc (Vaccinogen) is an immunotherapy company that develops products for the treatment of solid tumors. The company provides oncovax products. It provides immunotherapy products to treat solid tumors and commercializes autologous tumor vaccine products. Vaccinogen's products are us …
  • Banco BPI, S.A.:企業のM&A・事業提携・投資動向
    Banco BPI, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco BPI, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • DRB-HICOM Defense Technologies Sdn Bhd:企業の戦略・SWOT・財務情報
    DRB-HICOM Defense Technologies Sdn Bhd - Strategy, SWOT and Corporate Finance Report Summary DRB-HICOM Defense Technologies Sdn Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Shree Rama Newsprint Limited (RAMANEWS):企業の戦略的SWOT分析
    Shree Rama Newsprint Limited (RAMANEWS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • CooperSurgical Inc:企業のM&A・事業提携・投資動向
    CooperSurgical Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CooperSurgical Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Oncolix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Oncolix Inc (Oncolix) is a clinical stage biopharmaceutical company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant analogue to the human prolactin and acts as an antagonist to the prolactin receptor …
  • Beverages & More Inc:企業の戦略的SWOT分析
    Beverages & More Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆